Sichuan Academy Of Medical Sciences
Clinical trials sponsored by Sichuan Academy Of Medical Sciences, explained in plain language.
-
Can a sedative tame the storm of sepsis and save lives?
Disease control Not yet recruitingThis study tests whether giving a calming drug called dexmedetomidine early can help people with septic shock. The drug aims to calm an overactive nervous system, reduce organ damage, and improve survival. About 168 adults will receive either the drug or a placebo for 48 hours, a…
Phase: PHASE4 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New eye drops aim to slow diabetic retinopathy in small early trial
Disease control Not yet recruitingThis early-phase trial tests whether NPDR-01 eye drops can reduce tiny blood vessel bulges (microaneurysms) in the retina of people with non-proliferative diabetic retinopathy, a common complication of diabetes. Ten adults aged 18-75 with type 1 or type 2 diabetes will receive th…
Phase: EARLY_PHASE1 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Taurine: a new hope for MS patients?
Disease control Not yet recruitingThis study tests whether taking taurine alongside standard MS medications can reduce brain damage, relapses, and disability. About 80 adults with relapsing-remitting MS will take either their usual therapy alone or with added taurine for 24 months. Researchers will track MRI scan…
Phase: PHASE2 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated May 01, 2026 15:59 UTC